PharmExec Direct: Having trouble viewing the email? Click Here

In this ISSUE

How Did Things Get This Bad? Look in the Mirror, US Pharma

Data Disclosure: Sealing the Error Envelope

2016 Emerging Pharma Leaders — Nominate Now
Regulatory
No One Likes the Medicare Part B Pilot
Doctors and oncologists agree with pharma companies in opposing the latest proposal from the CMS to revise how it pays for drugs administered in doctors' offices, writes Jill Wechsler
... /Read more/
 
Advertisement
SPEED TO INSIGHT: 4 Strategies you need to maximize the value of your data assets
On Demand
Join Hewlett Packard Enterprise and Linguamatics as they discuss the right questions to ask about your company's analytics capabilities to gain a competitive advantage. Learn more
 
Transparency
Data Disclosure: Sealing the Error Envelope
With the emerging industry commitment to publicly disclose research and clinical trial results, two pivotal issues come to mind, writes William Looney
... /Read more/
 
Emerging Pharma Leaders
Pharm Exec’s Emerging Pharma Leaders 2016 — Nominate Now
Pharm Exec is looking for the fresh faces of pharma leadership. And we'd like your input. Tell us who you think should be included as one of our 2016 Emerging Pharma Leaders. These leaders are vital to the future of the industry, and you can help ensure they get the recognition they deserve. Fill out your nomination today
... /Read more/
Q&A
Taking the Reins Off Genomic Patient Data
Ambry Genetics' CEO discusses his company's decision to release the genetic information of its customers for free — a rare move, reportedly, for a commercial testing firm
... /Read more/
Big Data
Data Harmonization: Creating Order from Chaos
Elvis Pacelat asks why the prospect of harmonized content is so challenging, and what can pharma companies learn from other sectors about more optimal, modern ways of working and sharing data?
... /Read more/
 
Calendar
/ March 22–23: 9th Annual Oncology Commercialization and Market Access /
San Francisco, CA.
/ April 18–19: IRT Europe — Interactive Response Technologies in Clinical Trials /
Brussels, Belgium
/ June 21–22: Patient Engagement Solutions Summit /
Philadelphia, PA.
/ August 15–17: 10th Annual Forum on Transparency and Aggregate Spend /
Washington, DC.
/ December 13–14: Life Sciences Trade and Channel Strategies /
Philadelphia, PA
 
Industry update
//Bantam Pharmaceutical (New York, NY) appointed Michael A. Luther, Ph.D., as the company's President and Chief Executive Officer.//INC Research (Raleigh, NC) announced the appointment of Judith Ng-Cashin, MD, as Chief Scientific Officer.//PixarBio (Cambridge, MA) appointed David Kaplan as Vice President of Global Sales and Marketing.//
 
advertise with us / print subscribe / digital subscribe / visit pharmexec.com